Definitive Healthcare (DH) Cash & Equivalents (2020 - 2026)

Definitive Healthcare (DH) has 7 years of Cash & Equivalents data on file, last reported at $157.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 48.59% year-over-year to $157.6 million; the trailing twelve-month figure through Mar 2026 stood at $157.6 million (up 48.59% YoY), and the FY2025 full-year result was $163.6 million, up 55.28% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $157.6 million, down from $163.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $229.8 million in Q1 2022 and bottomed at $77.5 million in Q3 2023.
• The 5-year median for Cash & Equivalents is $131.0 million (2023), against an average of $140.4 million.
• The widest annual swing landed in 2023, when Cash & Equivalents plunged 66.15%; it then surged 77.65% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $146.9 million in 2022, then decreased by 10.86% to $131.0 million in 2023, then dropped by 19.54% to $105.4 million in 2024, then jumped by 55.28% to $163.6 million in 2025, then declined by 3.65% to $157.6 million in 2026.
• The last three Cash & Equivalents figures came in at $157.6 million (Q1 2026), $163.6 million (Q4 2025), and $108.3 million (Q3 2025), per Business Quant data.

Peer Comparison